Our Mission
Amplify51 Limited is a not-for-profit organisation committed to improving the health and well-being of women by promoting investment in women’s health.
Our goal is to accelerate research and translation of discoveries in prevention, diagnosis and treatment to address unmet needs in women’s health and close the gap in health outcomes between women and men.
“For all the efforts to improve gender equity over the past century, the gap between men’s health and women’s health remains wide, whether it’s in research, data, care or investment.”
Source: World Economic Forum 2024 In collaboration with the McKinsey Health Institute: Closing the Women's Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies, Insight Report Jan 2024 The Challenge
There is a significant gap in clinical understanding of women’s health
51% of the Australian population identify as women, yet medicine has historically treated the male body as the standard.
Women were largely excluded from medical trials for decades because of concerns around pregnancy risks and because scientists thought their hormonal changes would make study results less reliable, creating a significant gap in clinical understanding of women’s health that persists today.
Women’s health strategies are often narrowly focused on reproductive and gynaecological care
Women’s health is not limited to conditions that only affect women. Many common diseases - including cardiovascular disease, osteoporosis and Alzheimer’s disease - affect women differently and in some cases disproportionately, yet research and treatments tailored to women remain limited.
The data gap due to the gap in clinical understanding of the broader health needs of women is compounding the disparity in health outcomes
Delayed or misdiagnoses of diseases, less-effective treatments, and missed prevention opportunities mean women’s health needs are not seen, recorded, measured, prioritised or planned for.
When research results and clinical data are not including data relating to 51% of the population future planning of healthcare systems, reimbursement programs and analysis of market demand for therapeutics and services will be flawed.
Without prioritising sex and gender specific evidence based solutions and ensuring accurate sex and gender specific data is available for all patients, medics, educators, policy makers and investors the inequity and health risks faced by women will continue to negatively impact their lives.
NEW TEXT TO REPLACE ABOVE TEXT
The data gap stemming from the limited clinical understanding and the narrow focus of women’s health strategies women is compounding the disparity in health outcomes.
Delayed or misdiagnoses of diseases, less-effective treatments, and missed prevention opportunities mean women’s health needs are not seen, recorded, measured, prioritised or planned for.
When research results and clinical data don’t reflect experiences of 51% of the population future planning of healthcare systems, reimbursement programs and analysis of market demand for therapeutics and services will be flawed.
Without prioritising sex and gender specific evidence based solutions and ensuring accurate sex and gender specific data is available for all patients, medics, educators, policy makers and investors, the inequity and health risks faced by women will continue to negatively impact their lives.
The Opportunity
Multiple recent global reports estimate that addressing the historically ignored broader therapeutic areas for women could unlock a multi-billion-dollar market opportunity.
Many therapies already target conditions that affect women uniquely, differently, or disproportionately, yet are developed and commercialised with male biology as the default, limiting efficacy, adoption, and market reach. Addressing this gap creates a powerful lever for optimising existing assets.
Women exert a substantial impact on national economies - they make up of half of the population, half of the workforce, hold two-thirds of the wealth, and make the majority of household spending decisions. Resolving their unmet medical needs and maximising their wellbeing and productivity should be a national strategic priority.
With their health needs addressed, women will be better positioned to thrive - in education, in the workforce and in leadership - allowing them to live more fully throughout all stages of their lives and facilitating gender equity more broadly.
“Investments addressing the women’s health gap could add years to life and life to years - and potentially boost the global economy by $1 trillion annually by 2040.”
Source: World Economic Forum 2024 In collaboration with the McKinsey Health Institute: Closing the Women's Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies, Insight Report Jan 2024Our Action
Amplify51 activity is aligned with the Australian Government’s Department of Health (2019) National Women’s Health Strategy 2020–2030
01
Increase awareness of the investment opportunity in women’s health
Educate investors and policymakers on the commercial case for investing in the health of women by highlighting data on market growth, revenue models and return on investment potential, with successful case studies to demonstrate the economic opportunity.
02
Mobilise early and growth-stage capital
Connect strategic institutions, philanthropic organisations and impact investors to support innovative women’s health startups and expand access to essential services such as early diagnostics and preventative care.
Leverage national and international collaboration
Through shared data and aligned regulatory and policy reviews, build investment in data platforms, clinical trial networks, and regulatory and reimbursement approval pathways to ensure solutions are investable, scalable, and reach patients without undue delay.